Search

Search Results for: “”

  1. PRIVACY POLICY

  2. Management Team

    Terje Aarbogh Managing Director Phone: +45 3679 45096 Email: taa@cossynthesis.com Lone Undall-Behrend Nielsen Manager – Finance & Administration, Sourcing & Logogistic Phone: +45 3679 4640…

    Read more

  3. Cookie- og privatlivspolitik

    Cookiepolitik

  4. The facility

    Manufacturing is taking place in a well-equipped, up-to-date and efficient production facility comprising more than 8,000 m2 and including: • cGMP-compliant documentation and equipment with…

    Read more

  5. Investor

    From 1st October 2015 COS has raised EUR 10 million through the sale of Series A Preferred Stock to the American private equity firm, Signet…

    Read more

  6. Contact

    Chr. Olesen Synthesis A/S Kanalholmen 8-12 DK-2650 Hvidovre Denmark Tel.: +45 3679 4500 E-mail: info@cosynthesis.dk

  7. Structure and Management Team

  8. Pipeline

  9. Products

    Apomorphine hydrochloride (in development) Buprenorphine base Buprenorphine hydrochloride Buprenorphine intermediate Codeine phosphate Dexamfetamine base Dexamfetamine sulfate Hydromorphone hydrochloride Pramipexole dihydrochloride monohydrate (R)-5-(2-Aminopropyl)-2-methoxybenzenesulfonamide (Tamsulosine intermediate) Ranolazine…

    Read more

  10. About us

    Chr. Olesen Synthesis is a Danish manufacturer of APIs and advanced intermediates. Chr. Olesen Synthesis was established in late 2011 after the Chr. Olesen Group…

    Read more